CJC1295/Ipamorelin 6mg/6mg vial

CJC-1295 and Ipamorelin are synthetic peptides commonly used together as a growth hormone secretagogue stack to stimulate the body’s own production of growth hormone (GH). CJC-1295 is a growth hormone-releasing hormone (GHRH) analog that signals the pituitary to release GH and, depending on the form (with or without DAC), may support sustained GH levels. Ipamorelin is a growth hormone-releasing peptide (GHRP) that triggers GH release via the ghrelin receptor with minimal effects on cortisol or prolactin. The combination is thought to provide synergistic stimulation of GH secretion through complementary pathways. A 6 mg/6 mg vial typically refers to a compounded injectable formulation containing equal amounts of each peptide. This combination is used in peptide therapy protocols aimed at supporting lean muscle growth, fat metabolism, recovery from exercise, and overall vitality by enhancing GH and downstream IGF-1 levels. Potential effects include improved body composition, enhanced recovery, and better sleep quality, though evidence is primarily from small studies, clinical practice, and anecdotal reports rather than large, peer-reviewed trials.